Advancing patient care by guiding clients in discovering, developing, and delivering new treatments and medical devices to market.
We are driven by a passion to collaborate with clients in achieving their strategic goals—delivering safe, effective, and commercially successful treatments to patients faster. Throughout the Biopharma and MedTech product lifecycle, Strat Bio Partners engaged world class consultants to offer end-to-end solutions and transformative insights, leveraging industry-leading platforms like Cortellis and DRG Fusion.
Our experts drive innovation across Research & Development, Commercial Consulting Services, and Technology, supporting you every step of the way as you enhance patient lives and shape a healthier future
Product and Portfolio Strategy
Crafting impactful product and portfolio strategies requires a deep understanding of disease areas and industry dynamics. We empower our clients to capitalize on market opportunities and develop strategies that drive success.
With extensive expertise spanning from proof of concept to lifecycle management, our team provides strategic, data-driven insights to support clinical development, optimize product positioning, and enhance market adoption.
Our Offerings:
Therapy Area Strategy
New Market Entry Strategy
Growth and Value Maximization Strategy
Portfolio Optimization and Prioritization
Market, TA, Indication, and Asset Opportunity Assessments
Target Product Profile (TPP) Development and Testing
Demand Studies & Forecasting
Positioning & Competitive Differentiation Strategy
Integrated Patient Journey Analysis
Site of Care Analysis
BD&L Target Search
Commercial Due Diligence
Clinical, Economic, and Real-World Evidence
We provide expert consulting and technical support across the product journey, helping clients maximize the value of their existing evidence while identifying and addressing gaps to enhance access and reimbursement strategies in target markets.
Our multidisciplinary team includes health economists, statisticians, medical writers, in-house graphic designers, commercial assessment analysts, systematic reviewers, and COA specialists. This diverse expertise enables us to deliver tailored, end-to-end solutions that optimize market access throughout the product lifecycle.
Our Offerings:
Custom Epidemiology Studies
Real-World Evidence (RWE) Study Design & Execution (Epidemiology Studies, Registry Analysis, HCRU Analysis, Retrospective Chart Reviews, Prospective Studies)
Early Analysis & Economic Modeling
Clinical Outcomes Assessments (PROs & Patient Preference Studies)
Core Global Economic Models (CEMs & BIMs)
Systematic Literature Reviews & Network Meta-Analysis
Pricing and Market Access
Successful commercialization depends on a clear understanding of a product’s market access potential. With deep expertise and proprietary data assets, our team helps clients navigate the evolving complexities of global reimbursement landscapes. We provide strategic insights to anticipate regulatory and payer trends, define evidence requirements, and develop innovative approaches to optimize pricing and market access.
Our Offerings:
Access Landscapes & Account Journey Pathways
Indication Prioritization
Target Product Profile (TPP) Development & Testing
Gap Analysis & Evidence Generation Strategy
Launch Pricing Strategy
Payer & Account Archetyping, Segmentation & Engagement Planning
Contracting & Formulary Placement Strategy & Simulation
Mock Negotiation Workshops
HTA Submissions & Support
Customized solutions, powered by extensive expertise in drug commercialization and healthcare, to strengthen your strategy and drive success.
Design & Developed with ❤ by Byte-io